Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001332596-25-000013
Filing Date
2025-05-21
Accepted
2025-05-21 11:37:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 3984
  Complete submission text file 0001332596-25-000013.txt   5686
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Subject) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-52381 | Film No.: 25972096
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 497 CIRCLE FREEWAY CINCINNATI OH 45246
Business Address
Daly Joseph Patrick (Filed by) CIK: 0001332596 (see all company filings)

Type: SCHEDULE 13D/A